Mulay James
CG Oncology, Inc. Common stock · Director
Mulay James serves as a Director at CG Oncology, Inc., specializing in the healthcare sector. His recent insider activity includes multiple sales of CG Oncology, Inc. Common stock (CGON), with the latest disclosed transactions occurring on January 13, 2026. Notably, the largest sale recorded was valued at approximately $555.9K, reflecting a pattern of strategic divestment in the company's stock.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1M15.6k shares | SellApr 17, 2026 | $73.01 | $69.41 |